Liquid Biopsy Assay Can Predict CRC Recurrence Early : vimar

Patients testing positive for any of six ctDNA biomarkers on the liquid biopsy assay had a substantially higher risk for colorectal cancer recurrence.

Related Keywords

Houston , Texas , United States , China , California , Spain , Santiago De Compostela , Galicia , Juan Ruiz Ba , Kevan Morris , Ajay Goel , Shaobo Mo , Fudan University Shanghai Cancer Center , University Of Santiago De Compostela , Morris , City Of Hope Comprehensive Cancer Center , University Of Texas Md Anderson Cancer Center , Cancer Center , Hope Comprehensive Cancer Center , Colorectal Cancer , Disease Recurrence , Liquid Biopsy , Luid Biopsy , Luid Phase Biopsy , Cancer Blood Test , Ancer Saliva Test , Lood Biopsy , Erum Biopsy , Preventive Oncology , Adjuvant Chemotherapy , Biopsy , Methylation , Genomics , Genomic Medicine , Edicine Genomic , Biologic Therapy , Cancer , Alignant Neoplasia , Arcinoma , Chemotherapy , Biomarker , Iological Marker , Postoperative , Surgery , Blood , Tumor , Adjuva ,